|
Volumn 25, Issue 4, 2011, Pages 231-237
|
Combined treatment of photodynamic therapy and bevacizumab for choroidal neovascularization secondary to age-related macular degeneration.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
PHOTOSENSITIZING AGENT;
PORPHYRIN;
VERTEPORFIN;
AGED;
ARTICLE;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECT;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOLOGY;
PHOTOCHEMOTHERAPY;
RETINA MACULA DEGENERATION;
RETINA MACULA LUTEA;
RETROSPECTIVE STUDY;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROIDAL NEOVASCULARIZATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FUNDUS OCULI;
HUMANS;
INTRAVITREAL INJECTIONS;
MACULA LUTEA;
MACULAR DEGENERATION;
MALE;
PHOTOCHEMOTHERAPY;
PHOTOSENSITIZING AGENTS;
PORPHYRINS;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VISUAL ACUITY;
|
EID: 84862833324
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2011.25.4.231 Document Type: Article |
Times cited : (8)
|
References (0)
|